RBC Capital maintains Huntsman at Sector Perform, raises price target to $10 from $9

RBC Capital kept its 'Sector Perform' rating on Huntsman but increased its price target to $10 from $9, suggesting a 4.7% upside from the Nov 3 close of $9.55. Recent analyst price targets for Huntsman range from $9 to $10.

Original reporting
Published Nov 4, 2026, 4:49 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 4, 2026, 4:56 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
RBC Capital maintains Huntsman at Sector Perform, raises price target to $10 from $9 — source image
Decision brief

The 30-second read

$HUNBullishLow
01

Why it matters

The price target increase signals a modest bullish bias but likely limited trading impact.

02

Market read

Small but actionable for traders monitoring analyst upgrades in the chemicals sector.

03

What to watch

Potential supply chain constraints could limit upside.

Relevance 5/10Novelty 5/10Timing: today

Background

Huntsman Corp (HUN) is a specialty chemicals manufacturer. Analyst coverage is limited, making rating changes notable for traders.

Company-level read

Ticker impact

$HUNBullishMedium confidence
Context

RBC Capital raised Huntsman's price target to $10 from $9, indicating a modest upside.

Expected impact

likely modest upside as market prices in the higher target

Evidence & confidence

The target raise is small and reflects a modest upside; no immediate catalyst beyond the rating change.

Market effects

Minor impact on specialty chemicals sector as analysts adjust expectations.

Limited to U.S. investors tracking Huntsman.

Low

Counterpoint

Target raise may be overly optimistic given broader market volatility.

Key entities

  • RBC Capital

    Equity research firm that raised the price target.

  • Huntsman Corp

    Specialty chemicals producer.

Related articles

$HUNMed

KeyBanc raises Huntsman stock price target on merger synergies

KeyBanc raised its price target for Huntsman (NYSE:HUN) to $13, citing merger synergies with OLN and better-than-expected Q3 results. The stock trades at $9.45, with a Fair Value of $13.16. Huntsman reported mixed Q3 earnings, missing EPS estimates but exceeding revenue forecasts. Jefferies initiated coverage with a Buy rating and $12 target. The company faces rising input costs but aims for $100M EBITDA improvement in 2026.

$HUNMed

Huntsman Q3 Earnings Call Highlights

Huntsman (HUN) reported Q3 earnings, noting seasonal slowing and higher raw-material costs in North American MDI markets. The company expects 2027 industry MDI growth to be flat to 2% and sees growth opportunities in advanced materials and automotive applications. Huntsman generated $82M in free cash flow in Q3 and anticipates substantial cash inflow in Q4. Europe remains challenging due to high energy costs, while China's market shows stability.

$HUNMed

Huntsman Corp (HUN) (Q3 2026) Earnings Call Highlights: $100 Million EBITDA Boost

Huntsman Corp (HUN) reported a $100M EBITDA boost in Q3 2026, with CEO Peter Huntsman expressing confidence in meeting $300M synergy targets from the Olin merger. He discussed market positioning, cost management, and growth expectations, including GDP-plus growth in Advanced Materials through 2027. The company expects to cover its dividend and capex with operating cash flow, despite minimal cash flow in the first nine months.

$HUNMedAI 8/10

Huntsman: Q3 Earnings Snapshot

Huntsman Corp. (HUN) reported a Q3 loss of $18M, or 10 cents per share, missing analyst expectations of 7 cents per share. Adjusted earnings were 4 cents per share. Revenue was $1.72B, exceeding forecasts of $1.6B.